Bacteremia in patients with hematologic malignancies

Journal of the Formosan Medical Association

Volumn 97, Issue 6, 1998, Pages 405-409

  Wang, Fu Der ^a,b   Liu, Yin Ming ^a   Liu, Cheng Yi ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Agar dilution method; Bacteremia; Hematologic malignancy

Indexed keywords

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 0031870443     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Armstrong D: Empiric therapy for the immunocom-promised host. Rev Infect Dis 1991;13(suppl 9): 763-9.
2. Pizzo PA: Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328:1323-32.
3. Wade JC: Management of infection in patients with acute leukemia. Hematol Oncol Clin N Am 1993;7: 293-314.
4. th ed. New York: John Wiley, 1995; 2686-96.
5. Schimpff SC: Overview of empiric antibiotic therapy for the febrile neutropenic patient. Rev Infect Dis 1985;7:734-40.
6. Bodey GP: Empirical antibiotic therapy for fever in neutropenic patients. Clin Infect Dis 1993;17(suppl 2): 378-84.
7. Gunther G, Bjorkholm M: Septicemia in patients with hematological disorders and neutropenia. Scand J Infect Dis 1991;23:589-98.
8. Fredlund H, Bjoreman M, Kjellander J, et al.: A 10-year survey of clinically significant blood culture isolates and antibiotic susceptibilities from adult patients with hematological diseases at a major Swedish hospital. Scand J Infect Dis 1990;22:381-91.
9. Bruun B, Bangsborg J, Hovgaard D, et al. Bacteremia and candidemia in hematological malignancies: microbiological findings and antibiotic susceptibilities. Scand J Inject Dis 1988;20:503-9.
10. rd ed. Approved Standard. NCCLS document M7-A3, 1993.
11. Hovgaard D, Skinghoj P, Bangsborg J, et al.: Bacteremia and candidemia in hematological malignancies: clinical findings. Scand J Infect Dis 1988;20:495-501.
12. Johansson H, Sternby E, Ursing B: Septicemia in granulocytopenic patients: a shift in bacterial etiology. Scand J Infect Dis 1992;24:357-60.
13. Kiehn TE: Bacteremia and fungemia in the immunocom-promised patients. Eur J Clin Microbiol Infect Dis 1989;8:832-7.
14. Rubio M, Palau L, Romero Vivas J, et al.: Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect Control Hosp Epidemiol 1994;15:101-4.
15. European Organisation for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group. Gram-positive bacteremia in granulocytopenic cancer patients. Eur J Cancer 1990; 26:569-74.
16. Rintala E: Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies. Scand J Infect Dis 1994;26: 77-84.
17. Chen SH, Liang DC: Bacteremia in children with acute lymphoblastic leukemia. Acta Paed Sin 1993;34:167-72.
18. Wang FD, Jang TN, Liu CY: Infections in febrile granulocytopenic patients: clinical features and pathogens. J Formos Med Assoc 1996;95:410-3.
19. Ehni WF, Reller B, Ellison RT: Bacteremia in granulocytopenic patients in a tertiary-care general hospital. Rev Infect Dis 1991;13:613-9.
20. Bodey GP, Buckley M, Sathe YS: Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-40.
21. The EORTC International Antimicrobial Therapy Cooperative Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 1987;317:1692-8.
22. Klastersky J, Zinner SH, Calandra T, et al., and the EORTC Antimicrobial Therapy Cooperative Group: Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Eur J Cancer Clin Oncol 1988;24(suppl 1):35-45.
23. Shenep JL, Hughes WT, Robertson PK, et al.: Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N Engl J Med 1988;319:1053-8.
24. Rubin M, Hathorn JW, Marshall D, et al.: Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med 1988;108:30-5.
25. European Organization for Research and Treatment of Cancer (EORTC), International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. J Infect Dis 1991;163: 951-8.